Bain Capital Life Sciences Investors, LLC, 10% Owner at Olema Pharmaceuticals, Inc. (OLMA), bought 300,000 shares at $5.76 ($1.7M) on 2025-01-08, disclosed to the SEC on 2025-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HTFL | SELL | 2026-02-06 | $56.1M | — | Filing → |
| ANNX | BUY | 2023-05-30 | $639K | — | Filing → |
| RPID | BUY | 2021-07-21 | $2.0M | — | Filing → |